A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult

NCT07632573 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis (UC)
Ulcerative Colitis (Disorder)
Ulcerative Colitis Acute
IBD (Inflammatory Bowel Disease)
CD - Crohn's Disease

Interventions

DRUG: BDHK-2009 Tablets
DRUG: Placebo

Sponsor

Benethera (Shaoxing) Biotechnology Co., Ltd.